TrialNature communications2024

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment.

Gail B Cross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.